Brief: Chimeric Therapeutics Posts Net Loss For Year Attributable A$12.5 Mln
30/08/2024 02:42
Aug 30 (Reuters) - Chimeric Therapeutics Ltd CHM.AX :
* NET LOSS FOR YEAR ATTRIBUTABLE A$12.5 MILLION
Source text for Eikon: ID:nASX8wD54r
Further company coverage: CHM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial